Single agent growth-inhibitory effects have been reported in breast, colon, and meningioma tumor xenografts, which suggests that GHR antagonism as a monotherapy may have efficacy in some tumor types
(no photo available) 96 tests $1,001 KT-34898 Follistatin like 1 ELISA Kit (FSTL-1), Human For quantitative detection in human samples
Timeline by Potential Benefit All timelines above are speculative
bottom panel)
At 0.5%, suppression begins to fail within 7-14 days
For the regulation of variable splicing of neurexins, Traunmller, L showed that the RNA-binding proteins SLM1 and SLM2, which belong to the STAR (RNA signaling and activating factor) family, are expressed in a mutually exclusive manner but are not complementary in the regulation of the splice variants of neurexins